Korelasi antara indeks massa tubuh dan d-dimer dengan waktu konversi pasien rawat inap Covid-19

Ridia Dityarika, Netti Suharti, Desmawati Desmawati


Tujuan: Penelitian ini bermaksud untuk mengetahui korelasi antara IMT (Indeks Massa Tubuh) dan kadar D-dimer dengan waktu konversi COVID-19 pada pasien rawat inap; Metode: Studi potong lintang ini dilakukan terhadap 301 rekam medis pasien COVID-19 di RSUP Dr. M. Djamil Padang, periode Maret 2020-Desember 2021. Pengolahan data dilakukan dengan menggunakan aplikasi statistik berbasis komputer; Hasil: Kelompok umur terbesar dalam penelitian ini adalah lansia (>60 tahun) sejumlah 46%. Lebih dari setengah sampel penelitian adalah wanita (53,5%). Berat badan normal merupakan kelompok IMT dengan jumlah tertinggi yaitu 52,8%, dan proporsi pasien dengan penyakit penyerta sebesar 63,8%. Rerata IMT adalah 24,89 ± 4,772 kg/m2, konsentrasi D-dimer adalah 1948,36 ± 2611,606 ng/ml, dan waktu konversi adalah 11,48 ± 4,832 hari. Nilai rerata D-dimer tertinggi ditemukan pada lansia, pria, kelompok kurus dan pasien dengan penyakit penyerta. Rerata waktu konversi tertinggi ditemukan pada kelompok pria, pasien obesitas dan memiliki penyakit penyerta; Kesimpulan: Analisis kelompok obesitas menunjukkan korelasi yang signifikan secara statistik antara IMT dan nilai D-dimer dengan waktu konversi pada pasien COVID-19. Namun, analisis keseluruhan menunjukkan bahwa tidak ada hubungan yang signifikan secara statistik antara IMT dan nilai D-dimer dengan waktu konversi COVID-19 pada pasien yang dirawat di rumah sakit.


biomedical sciences: clinical sciences

Full Text:




Murdaca, G., Pioggia, G. and Negrini, S. (2020) ‘Vitamin D and Covid ‑ 19 : an update on evidence and potential therapeutic implications’, Clin Mol Allergy, 18(23), pp. 1–8.

Zhang, L. et al. (2020) ‘D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19’, J Thromb Haemost, 18(6), pp. 1324–1329.

Yao, Y. et al. (2020) ‘D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: A case control study’, Journal of Intensive Care, 8(49), pp. 1–11.

Rodriguez-Morales, A. J. et al. (2020) ‘Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis’, Travel Medicine and Infectious Disease, 34(March), pp. 1 - 13.

Demelo-Rodríguez, P. et al. (2020) ‘Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels’, Thrombosis Research, 192(May), pp. 23–26.

Léonard-Lorant, I. et al. (2020) ‘Acute pulmonary embolism in patients with COVID-19 at CT angiography and relationship to d-dimer levels’, Radiology, 296(3), pp. E189–E191.

de Frel, D. L. et al. (2020) ‘The Impact of Obesity and Lifestyle on the Immune System and Susceptibility to Infections Such as COVID-19’, Front. Nutr, 7(July), pp. 1–12.

Albercaa, R. W. et al. (2021) ‘Obesity as a risk factor for COVID-19: an overview’, Critical Reviews in Food Science and Nutrition, 61(13), pp. 2262–2276.

Dobner, J. and Kaser, S. (2018) ‘Body mass index and the risk of infection - from underweight to obesity’, Clinical Microbiology and Infection, 24(1), pp. 24–28.

Kompaniyets, L. et al. (2021) ‘Body Mass Index and Risk for COVID-19–Related Hospitalization, Intensive Care Unit Admission, Invasive Mechanical Ventilation, and Death — United States, March–December 2020’, MMWR Surveillance Summaries, 70(10), pp. 355–361.

Ye, P. et al. (2021) ‘Both Underweight and Obesity Are Associated With an Increased Risk of Coronavirus Disease 2019 (COVID-19) Severity’, Front. Nutr, 8(649422), pp. 1–8.

Abrahim, et al (2020) ‘Time to recovery and its predictors among adults hospitalized with COVID-19 : A prospective cohort study in Ethiopia’, PLoS ONE, 15(12), pp. 1–11.

Moriconi, D. et al. (2020) ‘Obesity prolongs the hospital stay in patients affected by COVID-19, and may impact on SARS-COV-2 shedding’, Obesity Research and Clinical Practice, 14(3), pp. 205–209.

Wang, Z. et al. (2022) ‘What are the risk factors of hospital length of stay in the novel coronavirus pneumonia (COVID-19) patients? A survival analysis in southwest China’, PLoS ONE, 17(1), pp. 14–23.

Ferreira, M. E. R. et al. (2021) ‘Covid-19 and obesity: A systematic review and meta-analysis on the pre-existing clinical conditions, covid-19 symptoms, laboratory findings and clinical outcomes’, EXCLI Journal, 20, pp. 1610–1614.

Kwok, S. et al. (2020) ‘Obesity: A critical risk factor in the COVID-19 pandemic’, Clin Obes, 10, pp. 1 - 11.

Gao, M. et al. (2021) ‘Associations between body-mass index and COVID-19 severity in 6•9 million people in England: a prospective, community-based, cohort study’, Lancet Diabetes Endocrinol, 9(6), pp. 350–359.

Gao, F. et al. (2020) ‘Obesity Is a Risk Factor for Greater COVID-19 Severity’, Diabetes Care, 43(7), pp. E72–E74.

Rosenthal, N. et al. (2020) ‘Risk Factors Associated with In-Hospital Mortality in a US National Sample of Patients with COVID-19’, JAMA Network Open, 3(12), pp. 1–14.

Bajaj, V. et al. (2021) ‘Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections?’, Front. Physiol, 11(January), pp. 1–23.

Hu, X. et al. (2020) ‘Factors associated with negative conversion of viral RNA in patients hospitalized with COVID-19’, Science of the Total Environment, 728(175), pp. 1 - 7.

Fadl, N., Ali, E. and Salem, T. Z. (2021) ‘COVID-19: Risk Factors Associated with Infectivity and Severity’, Scand J Immunol, 93(6), pp. 1–14.

Sabbatini, A.R. and Kararigas, G. (2020) ‘Menopause-Related Estrogen Decrease and the Pathogenesis of HFpEF’, JACC, 75(9), pp. 1074–1082.

Pei, J. et al. (2017) ‘Cardiorenal disease connection during post-menopause: The protective role of estrogen in uremic toxins induced microvascular dysfunction’, International Journal of Cardiology, 238(2017), pp. 22–30.

Caccialanza, R. et al. (2021) ‘Nutritional parameters associated with prognosis in non-critically ill hospitalized COVID-19 patients: The NUTRI-COVID19 study’, Clinical Nutrition, (2021), pp. 1 - 8.

Vitale, N. (2021) ‘Body Mass Index and Covi d-19: Likely Causes for Obesity and Undernutrition Correlation with Disease Severity’, J Cell Immuno, 3(4), pp. 5–10.

Li, B. et al. (2020) ‘Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China’, Clinical Research in Cardiology, 109(5), pp. 531–538.

Zhou, F. et al. (2020) ‘Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study’, Lancet, 395(9),pp. 1054–1062.

Neto, J. A. B. et al. (2022) ‘Association Between Underweight and Excess Body Weight Before Sars-Cov-2 Infection and Clinical Outcomes of Covid-19: Multicenter Study’, Nutrition, pp. 1 - 33.

Weitz, J. I., Fredenburgh, J. C. and Eikelboom, J. W. (2017) ‘A Test in Context: D-Dimer’, JACC, 70(19), pp. 2411–2420.

Candrawati, N. W. and Cassidy, W. R. (2021) ‘Interpretasi nilai Cycle Threshold (CT) Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) SARS-CoV-2 pada pasien hamil dengan uji antibodi SARS-CoV-2 positif dan COVID-19 asimtomatik’, Intisari Sains Medis, 12(3), pp. 822 - 827.

Jordan, R. E., Adab, P. and Cheng, K. K. (2020) ‘Covid-19: Risk factors for severe disease and death’, The BMJ, 368(March), pp. 1–2.

Pranata, R. et al. (2021) ‘Body mass index and outcome in patients with COVID-19: A dose–response meta-analysis’, Diabetes and Metabolism, 47(2), pp. 1 - 9.

Borga, M. et al. (2018) ‘Advanced body composition assessment: From body mass index to body composition profiling’, J Investig Med, 66(5), pp. 887–895.

Shah, S. et al. (2020) ‘No correlation between Ct values and severity of disease or mortality in patients with COVID 19 disease’, Indian Journal of Medical Microbiology, 39(2021), pp. 116 – 117.

Ragab, D. et al. (2020) ‘The COVID-19 Cytokine Storm; What We Know So Far’, Front. Immunol, 11(1446), pp. 1–8.

Alwarawrah, Y., Kiernan, K. and MacIver, N. J. (2018) ‘Changes in nutritional status impact immune cell metabolism and function’, Front. Immunol, 9(MAY), pp. 1–14.

Rossi, E. L. et al. (2016) ‘Obesity-associated alterations in inflammation, epigenetics, and mammary tumor growth persist in formerly obese mice’, Cancer Prev Res, 9(5), pp. 339–348.

Gwela, A. et al. (2019) ‘Undernutrition, Host Immunity and Vulnerability to Infection among Young Children’, Pediatric Infectious Disease Journal, 38(8), pp. E175–E177.

Womble, J. T. et al. (2021) ‘Imbalanced coagulation in the airway of type-2 high asthma with comorbid obesity’, Journal of Asthma and Allergy, 14, pp. 967–980.